Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion type Assertion NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_head.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion description "[In this review, we focus on recent clinical trials and analyze the factors that determine clinical responses, including the following: 1) the composition of the CAR; 2) the preparation of CAR-modified T Cells; 3) the clinical treatment schedule; 4) the patient characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_provenance.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion evidence source_evidence_literature NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_provenance.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion SIO_000772 23256743 NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_provenance.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion wasDerivedFrom befree-20140225 NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_provenance.
- NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_assertion wasGeneratedBy ECO_0000203 NP185869.RA12Jqno2LBM3fg_qV-Chy-tXek1j8FSJ1Y96hsOCAKrs130_provenance.